Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

LC-OCT can help identify lupus-related scarring hair loss by spotting unique features.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Clove essential oil nanoemulgel effectively reduces skin inflammation and is a promising alternative to traditional anti-inflammatory drugs.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Alopecia Areata might be linked to Crohn's disease.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.